10.3 USE OF MICROLIFE BP WATCH IS A FEASIBLE APPROACH TO DETERMINE INTER-ARM BLOOD PRESSURE DIFFERENCES IN A CLINICAL SETTING
Aim: The aim of this study is to evaluate the feasibility of Microlife Watch BP for measuring bilateral blood pressure (BP) in a clinical setting. Method: 339 patients (85% diabetic) scheduled for ambulatory blood pressure monitoring at the outpatient clinic for endocrinology, Silkeborg Regional Ho...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2016-11-01
|
| Series: | Artery Research |
| Online Access: | https://www.atlantis-press.com/article/125930461/view |
| _version_ | 1811300746217390080 |
|---|---|
| author | Christoffer Krogager Esben Laugesen Niklas B. Rossen Per L. Poulsen Mogens Erlandsen Klavs W. Hansen |
| author_facet | Christoffer Krogager Esben Laugesen Niklas B. Rossen Per L. Poulsen Mogens Erlandsen Klavs W. Hansen |
| author_sort | Christoffer Krogager |
| collection | DOAJ |
| description | Aim: The aim of this study is to evaluate the feasibility of Microlife Watch BP for measuring bilateral blood pressure (BP) in a clinical setting.
Method: 339 patients (85% diabetic) scheduled for ambulatory blood pressure monitoring at the outpatient clinic for endocrinology, Silkeborg Regional Hospital, were examined with simultaneously bilateral BP measurements. A fully automatic, oscillometric device was used and two successive measurements were made.
Results: 9,1% of the patients had a clinically significant inter-arm blood pressure difference (IAD) of ≥10mmHg in the first set of measurements. Mean IAD in the first measurement was -0,3mmHg 6.6. Twenty-three patients had a normal IAD in the first set of measurements but IAD ≥10mmHg in the second set of measurements. Only one of the patients with an IAD ≥10mmHg had a change in the arm with the highest blood pressure. The 95 % Limits of Agreement (LoA) for the mean interarm difference for a single measurement was 13.2 mmHg.
Conclusion: Microlife WatchBP measurement is a feasible method to determine IAD in a clinical setting. Bilateral BP measurements should be performed at first visit to help the clinician choose the right arm for further BP evaluations. |
| first_indexed | 2024-04-13T06:56:02Z |
| format | Article |
| id | doaj.art-66fe4a0923e9427faf75109ce57cd86c |
| institution | Directory Open Access Journal |
| issn | 1876-4401 |
| language | English |
| last_indexed | 2024-04-13T06:56:02Z |
| publishDate | 2016-11-01 |
| publisher | BMC |
| record_format | Article |
| series | Artery Research |
| spelling | doaj.art-66fe4a0923e9427faf75109ce57cd86c2022-12-22T02:57:15ZengBMCArtery Research1876-44012016-11-011610.1016/j.artres.2016.10.08110.3 USE OF MICROLIFE BP WATCH IS A FEASIBLE APPROACH TO DETERMINE INTER-ARM BLOOD PRESSURE DIFFERENCES IN A CLINICAL SETTINGChristoffer KrogagerEsben LaugesenNiklas B. RossenPer L. PoulsenMogens ErlandsenKlavs W. HansenAim: The aim of this study is to evaluate the feasibility of Microlife Watch BP for measuring bilateral blood pressure (BP) in a clinical setting. Method: 339 patients (85% diabetic) scheduled for ambulatory blood pressure monitoring at the outpatient clinic for endocrinology, Silkeborg Regional Hospital, were examined with simultaneously bilateral BP measurements. A fully automatic, oscillometric device was used and two successive measurements were made. Results: 9,1% of the patients had a clinically significant inter-arm blood pressure difference (IAD) of ≥10mmHg in the first set of measurements. Mean IAD in the first measurement was -0,3mmHg 6.6. Twenty-three patients had a normal IAD in the first set of measurements but IAD ≥10mmHg in the second set of measurements. Only one of the patients with an IAD ≥10mmHg had a change in the arm with the highest blood pressure. The 95 % Limits of Agreement (LoA) for the mean interarm difference for a single measurement was 13.2 mmHg. Conclusion: Microlife WatchBP measurement is a feasible method to determine IAD in a clinical setting. Bilateral BP measurements should be performed at first visit to help the clinician choose the right arm for further BP evaluations.https://www.atlantis-press.com/article/125930461/view |
| spellingShingle | Christoffer Krogager Esben Laugesen Niklas B. Rossen Per L. Poulsen Mogens Erlandsen Klavs W. Hansen 10.3 USE OF MICROLIFE BP WATCH IS A FEASIBLE APPROACH TO DETERMINE INTER-ARM BLOOD PRESSURE DIFFERENCES IN A CLINICAL SETTING Artery Research |
| title | 10.3 USE OF MICROLIFE BP WATCH IS A FEASIBLE APPROACH TO DETERMINE INTER-ARM BLOOD PRESSURE DIFFERENCES IN A CLINICAL SETTING |
| title_full | 10.3 USE OF MICROLIFE BP WATCH IS A FEASIBLE APPROACH TO DETERMINE INTER-ARM BLOOD PRESSURE DIFFERENCES IN A CLINICAL SETTING |
| title_fullStr | 10.3 USE OF MICROLIFE BP WATCH IS A FEASIBLE APPROACH TO DETERMINE INTER-ARM BLOOD PRESSURE DIFFERENCES IN A CLINICAL SETTING |
| title_full_unstemmed | 10.3 USE OF MICROLIFE BP WATCH IS A FEASIBLE APPROACH TO DETERMINE INTER-ARM BLOOD PRESSURE DIFFERENCES IN A CLINICAL SETTING |
| title_short | 10.3 USE OF MICROLIFE BP WATCH IS A FEASIBLE APPROACH TO DETERMINE INTER-ARM BLOOD PRESSURE DIFFERENCES IN A CLINICAL SETTING |
| title_sort | 10 3 use of microlife bp watch is a feasible approach to determine inter arm blood pressure differences in a clinical setting |
| url | https://www.atlantis-press.com/article/125930461/view |
| work_keys_str_mv | AT christofferkrogager 103useofmicrolifebpwatchisafeasibleapproachtodetermineinterarmbloodpressuredifferencesinaclinicalsetting AT esbenlaugesen 103useofmicrolifebpwatchisafeasibleapproachtodetermineinterarmbloodpressuredifferencesinaclinicalsetting AT niklasbrossen 103useofmicrolifebpwatchisafeasibleapproachtodetermineinterarmbloodpressuredifferencesinaclinicalsetting AT perlpoulsen 103useofmicrolifebpwatchisafeasibleapproachtodetermineinterarmbloodpressuredifferencesinaclinicalsetting AT mogenserlandsen 103useofmicrolifebpwatchisafeasibleapproachtodetermineinterarmbloodpressuredifferencesinaclinicalsetting AT klavswhansen 103useofmicrolifebpwatchisafeasibleapproachtodetermineinterarmbloodpressuredifferencesinaclinicalsetting |